Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2026-04-18 14:38:08 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1021/acs.jmedchem.6b01751
文献链接: https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b01751
其他信息:
出版社: American Chemical Society (ACS)
作者: Philip A. Harris; Scott B. Berger; Jae U. Jeong; Rakesh Nagilla; Deepak Bandyopadhyay; Nino Campobasso; Carol A. Capriotti; Julie A. Cox; Lauren Dare; Xiaoyang Dong; Patrick M. Eidam; Joshua N. Finger; Sandra J. Hoffman; James Kang; Viera Kasparcova; Bryan W. King; Ruth Lehr; Yunfeng Lan; Lara K. Leister; John D. Lich; Thomas T. MacDonald; Nathan A. Miller; Michael T. Ouellette; Christina S. Pao; Attiq Rahman; Michael A. Reilly; Alan R. Rendina; Elizabeth J. Rivera; Michelle C. Schaeffer; Clark A. Sehon; Robert R. Singhaus; Helen H. Sun; Barbara A. Swift; Rachel D. Totoritis; Anna Vossenkämper; Paris Ward; David D. Wisnoski; Daohua Zhang; Robert W. Marquis; Peter J. Gough; John Bertin
